$SWBI

SMITH & WESSON BRANDS, INC.

Insider trades

No enriched coverage for $SWBI in the last 7 days.

No SEC Form 4 filings for $SWBI in the last 30 days.

See all $SWBI insider activity →
Low

The $10K Portfolio: Gunnin’ for Some More Smith & Wesson

The FBI reported July firearm background checks rose 9.3% to 2,194,563 versus July 2025, the second straight monthly increase. The article links checks to firearm demand and notes exposure for Smith & Wesson (SWBI) and Sturm Ruger (RGR). It also lists analyst rating/price-target updates for OCUL, RKLB, VELO, and ONDS, plus upcoming earnings expectations for several stocks.

SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds By Investing.com

Smith & Wesson Brands (SWBI) reported fiscal Q4 2026 EPS of $0.36 vs $0.21 consensus and revenue of $178.4M vs $142.3M forecast, a 71.4% EPS beat, after which the stock jumped. GEO Group (GEO) traded near its 52-week high after Q1 FY2026 EPS of $0.29 vs $0.19 expected and revenue of $705.2M, with immigration enforcement spending cited as a tailwind.

SWBI sentiment & insider activity

Recent SWBI coverage spans market movers, earnings and sector analysis.

What's driving SWBI

  • Higher background checks are framed as supportive for firearm demand, which the article links to potential incremental buying in SWBI.

    thestreet.com · Aug 4, 2026

  • Earnings beat plus policy-driven firearm demand narrative supports near-term upside, but guidance risk remains into summer trough.

    investing.com · Jul 2, 2026

  • SWBI has a clear earnings beat catalyst, supporting a higher-conviction near-term trade versus peers.

    finance.yahoo.com · Jun 23, 2026

  • Sales growth and product momentum are likely to support near-term sentiment, but the article doesn’t provide guidance beyond FY26 net sales growth.

    boston.com · Jun 18, 2026

  • Earnings beat is the immediate catalyst supporting momentum and near-term positioning.

    benzinga.com · Jun 18, 2026

alphai scores every news story that mentions SWBI with an AI model for sentiment and relevance, and aggregates insider trades from SMITH & WESSON BRANDS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SWBI

Score

The $10K Portfolio: Gunnin’ for Some More Smith & Wesson

The FBI reported July firearm background checks rose 9.3% to 2,194,563 versus July 2025, the second straight monthly increase. The article links checks to firearm demand and notes exposure for Smith & Wesson (SWBI) and Sturm Ruger (RGR). It also lists analyst rating/price-target updates for OCUL, RKLB, VELO, and ONDS, plus upcoming earnings expectations for several stocks.

Stocks Set to Open Mixed as Investors Weigh U.S.-Iran Progress, PCE Inflation Data and Fed Speak Awaited

U.S. S&P 500 and Nasdaq 100 futures pointed to a mixed Wall Street open after a long weekend. Qatar and Pakistan said the U.S. and Iran agreed on a 60-day roadmap toward a final peace deal, including a mechanism for technical talks and Strait of Hormuz safety. Markets also await U.S. PCE inflation data and Fed speeches; the 10-year Treasury yield rose to 4.49%.

$SWBIMed

Smith & Wesson reports surge in firearms sales

Smith & Wesson reported a 27% year-over-year jump in fourth-quarter net sales to $178.4 million, citing strong handgun demand and new product rollouts, despite declining U.S. background checks. For fiscal 2026, it forecast net sales up more than 10% to $523.8 million. The company also plans major Springfield facility investments before April 2027.

$SWBIMed

Stock Market Today: Dow Jones, Nasdaq 100 Futures Surge Following Sharp Sell-Off As Fed Kept Rates Unchan

U.S. stock futures rose Thursday after Tuesday’s sharp sell-off, with markets pricing a 72.2% chance the Fed holds July rates unchanged (CME FedWatch). The 10-year Treasury yield was 4.45% and the 2-year 4.17%. Key movers: Smith & Wesson +15.37% on better Q4 results; Safe Bulkers +3.40% on better Q1 results; Sleep Number -55.90% after Nasdaq delisting plans following Chapter 11. Investors watch jobless claims and the Philly Fed survey.

Wall Street futures bounce back as US-Iran deal optimism balances hawkish Fed

Wall Street futures rose after prior-session declines tied to expectations of further Fed rate hikes, with CME Group’s FedWatch showing a 50% chance of a 25 bp September move. Oil fell, supporting hopes inflation cools. US-Iran released an interim deal extending the ceasefire 60 days. Intel gained 8.4% on Trump’s comments about Apple chip work; Accenture fell 11.1% on a reduced revenue outlook.

The next two weeks could be a bumpy ride for U.S. stocks. Buy any dip, this strategist says.

Citadel Securities strategist Scott Rubner said U.S. stocks may face volatility over the next two weeks due to the largest options expiration on record ($8.3 trillion, 18% above the prior record) and quarter-end pension rebalancing. He expects a more favorable setup after July 1, citing retirement/ETF flows, record retail activity, and robust buybacks (over $925 billion authorized in 2026).

$SWBIMedAI 8/10

Smith & Wesson Brands, Inc: Smith & Wesson Brands, Inc. Reports Fourth Quarter and Full Fiscal 2026 Financial Results

Smith & Wesson Brands reported fourth-quarter fiscal 2026 results ended April 30, 2026: net sales rose to $178.4M (+26.7% y/y), gross margin to 29.8%, and GAAP EPS to $0.36 from $0.19. GAAP net income was $16.2M. Full-year net sales were $523.8M (+10.4%); GAAP EPS was $0.41. The company also authorized a $0.13 quarterly dividend.

$SWBIMed

SMITH & WESSON BRANDS, INC. (SWBI): Results of Operations and Financial Condition

SMITH & WESSON BRANDS, INC. (SWBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d100270dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Smith & Wesson Brands, Inc. Reports Fourth Quarter and Full Fiscal 2026 Financial Results • Q4 Net Sales of $178.4 Million • Q4 Gross Margin of 29.8% • Q4 EPS of $0.36/Share • Q4 Cash from Operations of $74.6 million MARYVI

Related tickers